Article
Genetic Screening of Patients with Thyrotoxic Hypokalemic Periodic Paralysis: An Experience from a Tertiary Care Hospital in the Northeast of Brazil.
Endocrine, metabolic & immune disorders drug targets - 1 Jan 2021
Gbefon Cossi Y, Sobral Carla P S, Caldas Adriana, Rocha Viviane C C, Azulay Rossana S S, Nascimento Gilvan C, Damianse Sabrina S P, Gaspar Silvia A S, Faria Manuel S, Magalhães Marcelo
Abstract excerpt
BACKGROUND: Thyrotoxic Hypokalemic Periodic Paralysis (THPP) is a rare neuromuscular disease characterized by recurrent episodes of skeletal muscle weakness associated with hypokalemia. Alterations in protein-encoding genes that are part of ion channels seem to be related to the development of this disease. However, the pathogenic potential of some variants in these genomic regions is not yet fully understood....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
